You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
29 August 2023
Kintor Pharma Announces 2023 Interim Results and Recent Business Highlights
12 May 2023
Kintor Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US
31 March 2023
Kintor Pharma Announces 2022 Annual Results and Recent Business Progress
29 March 2023
Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China
21 March 2023
Kintor Pharma’s KX-826 and GT20029 for Treatment of Androgenetic Alopecia (AGA) and Acne Presented at AAD 2023
13 February 2023
Kintor Pharma Announces Positive Top-line U.S. Phase I Trial Results of GT20029, the World’s First Topical Use PROTAC Compound